NCT01101568View on ClinicalTrials.gov

A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

April 14, 2010

Primary Completion Date

June 24, 2010

Study Completion Date

June 24, 2010

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Simvastatin

Simvastatin 40mg (single dose) on Days 1 and 10.

DRUG

Rosuvastatin

Rosuvastatin 10mg (single dose) on Days 3 and 12.

DRUG

GSK1292263

GSK1292263 300mg BID Days 6 to 14.

Trial Locations (1)

78744

GSK Investigational Site, Austin

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01101568 - A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy Subjects | Biotech Hunter | Biotech Hunter